Pharmanutra S.p.A. (BIT:PHN)
Italy
· Delayed Price · Currency is EUR 47.70
-1.70 (-3.44%)
Jun 13, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Direct | 63.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Direct Growth | 10.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Indirect | 31.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Indirect Growth | 35.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Akern | 5.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Akern Growth | 156.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Italy | 67.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy Growth | 14.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 16.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 29.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East | 10.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East Growth | 35.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South America | 1.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Far East | 1.55M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Far East Growth | 84.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 53.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|